These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4062330)

  • 21. [Current state and prospects of the use of cygnoline in the treatment of psoriasis].
    Ciesielska J
    Przegl Dermatol; 1985; 72(1):77-90. PubMed ID: 3892593
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antipsoriatic effect of dithranol (anthralin). 2].
    Raab W
    Hautarzt; 1975 Sep; 26(9):456-9. PubMed ID: 1102494
    [No Abstract]   [Full Text] [Related]  

  • 23. Detection of anthralin in skin during treatment.
    Juhlin L; Schroot B
    Acta Derm Venereol Suppl (Stockh); 1985; 120():27-9. PubMed ID: 3869415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel wax stick preparation of anthralin.
    Chalmers RJ; Marks JM; Shuster S
    Acta Derm Venereol; 1982; 62(2):181-2. PubMed ID: 6179353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dithranol-stick prescription for simplified ambulatory psoriasis therapy].
    Wätzig V
    Dermatol Monatsschr; 1983; 169(8):533-4. PubMed ID: 6628791
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of the treatment of psoriasis with dithranol in comparison with a combination of dithranol and a corticosteroid].
    Gloor M; Graf R; Wirth H; Landau M
    Hautarzt; 1983 Oct; 34(10):500-3. PubMed ID: 6643055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dithranol cream.
    Seville RH; Walker GB; Whitefield M
    Br J Dermatol; 1979 Apr; 100(4):475-6. PubMed ID: 378254
    [No Abstract]   [Full Text] [Related]  

  • 28. Low strength anthralin in psoriasis.
    Montes LF; Wilborn WH; Brody I
    J Cutan Pathol; 1979 Dec; 6(6):445-56. PubMed ID: 42654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-contact dithranol therapy.
    Sharpe G; Farr PM
    Br J Dermatol; 1986 Apr; 114(4):518-9. PubMed ID: 3964552
    [No Abstract]   [Full Text] [Related]  

  • 30. [Suppression of dithranol erythema by the addition of tar in short-term therapy].
    Wozel G; Barth J
    Dermatol Monatsschr; 1985; 171(12):818-9. PubMed ID: 4092792
    [No Abstract]   [Full Text] [Related]  

  • 31. Short-duration dithranol therapy for psoriasis.
    Hindryckx P; De Bersaques J
    Dermatologica; 1983; 167(6):304-6. PubMed ID: 6662252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short contact dithranol therapy--twice daily and high concentration regimes.
    Statham BN; Rowell NR
    Br J Dermatol; 1985 Aug; 113(2):245-6. PubMed ID: 4027191
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of a tar admixture to dithranol-salicylic-acid-white-petrolatum therapy on the cytokinetics of psoriasis].
    Schulze HJ; Steigleder GK; Pullmann H; Bloedhorn H
    Z Hautkr; 1984 Mar; 59(5):288-90, 295-7. PubMed ID: 6719979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short contact anthralin therapy of psoriasis with and without UV-irradiation and maintenance schedule to prevent relapses.
    Brun P; Juhlin L; Schalla W
    Acta Derm Venereol; 1984; 64(2):174-7. PubMed ID: 6203312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New chemical stabilizers, vehicles and delivery systems to enhance efficacy of low strength anthralin formulations.
    van Scott EJ; Yu RJ
    Br J Dermatol; 1981 Aug; 105 Suppl 20():35-8. PubMed ID: 7284262
    [No Abstract]   [Full Text] [Related]  

  • 36. An open assessment of 0.1% dithranol in a 17% urea base ('Psoradrate' 0.1%) in the treatment of psoriasis of children.
    Guerrier CJ; Porter DI
    Curr Med Res Opin; 1983; 8(6):446-50. PubMed ID: 6342960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of dithranol cream, 0.25% and 0.1%, and dithranol ointment 0.25% in the treatment of psoriasis.
    Fredriksson T
    Pharmatherapeutica; 1983; 3(7):496-8. PubMed ID: 6366807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited application period for dithranol in psoriasis. Preliminary report on penetration and clinical efficacy.
    Schaefer H; Farber EM; Goldberg L; Schalla W
    Br J Dermatol; 1980 May; 102(5):571-3. PubMed ID: 7387901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anthralin. Different concentration effects on epidermal cell DNA synthesis rates in mice and clinical responses in human psoriasis.
    Lowe NJ; Breeding J
    Arch Dermatol; 1981 Nov; 117(11):698-700. PubMed ID: 7316528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of short-contact anthralin therapy to an ultraviolet B phototherapy regimen: assessment of efficacy.
    Lebwohl M; Berman B; France DS
    J Am Acad Dermatol; 1985 Nov; 13(5 Pt 1):780-4. PubMed ID: 4078074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.